
TDACU P/E Ratio
P/E Ratio as of Oct 13, 2025: 75.54
Average75.46
Median75.54
Minimum75.25
Maximum75.69
75.54
Past Month+0.29 (0.39%)
The P/E ratio for TDACU is 75.54 as of Oct 13, 2025. This represents a increase of 201.08% compared to its 12-month average P/E ratio of 25.09. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Translational Development Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Translational Development Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Translational Development Acquisition Corp to industry peers.
Translational Development Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Translational Development Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Translational Development Acquisition Corp to industry peers.
TDACU P/E Ratio Insights
See Translational Development Acquisition Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TDACU
Order type
Buy in
Order amount
Est. shares
0 shares
TDACU P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Oct 1, 2025 | — | 75.69 |
Sep 2, 2025 | — | 74.96 |
Aug 12, 2025 | — | 74.96 |
Jul 21, 2025 | — | 75.47 |
TDACU End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 75.54 | — |
FAQs About Translational Development Acquisition Corp (TDACU) P/E ratio
The latest P/E ratio of TDACU is 75.54, as of Oct 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Translational Development Acquisition Corp’s last 12-month average P/E ratio is 25.09, compared to its current P/E ratio of 75.54. This reflects a increase of 201.08%.
Translational Development Acquisition Corp’s current P/E ratio of 75.54 is higher than its last 12-month average P/E of 25.09. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Translational Development Acquisition Corp’s average P/E ratio over the last 3 years is 8.36. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Translational Development Acquisition Corp’s average P/E ratio over the last 5 years is 5.02. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.